Free Trial

BATM Advanced Communications (BVC) Competitors

BATM Advanced Communications logo
GBX 13.61 -0.44 (-3.13%)
As of 05:16 AM Eastern

BVC vs. TSTL, SPEC, AKR, CNSL, ODX, CTEC, AMS, HZD, AGY, and FARN

Should you be buying BATM Advanced Communications stock or one of its competitors? The main competitors of BATM Advanced Communications include Tristel (TSTL), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Advanced Medical Solutions Group (AMS), Horizon Discovery Group plc (HZD.L) (HZD), Allergy Therapeutics (AGY), and Faron Pharmaceuticals Oy (FARN). These companies are all part of the "medical" sector.

BATM Advanced Communications vs.

BATM Advanced Communications (LON:BVC) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.

Tristel has a net margin of 15.47% compared to BATM Advanced Communications' net margin of -0.21%. Tristel's return on equity of 20.43% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-0.21% -0.22% 0.58%
Tristel 15.47%20.43%9.89%

BATM Advanced Communications received 42 more outperform votes than Tristel when rated by MarketBeat users. However, 57.36% of users gave Tristel an outperform vote while only 49.10% of users gave BATM Advanced Communications an outperform vote.

CompanyUnderperformOutperform
BATM Advanced CommunicationsOutperform Votes
190
49.10%
Underperform Votes
197
50.90%
TristelOutperform Votes
148
57.36%
Underperform Votes
110
42.64%

BATM Advanced Communications has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500. Comparatively, Tristel has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500.

Tristel has lower revenue, but higher earnings than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£130.32M0.55-£278.26K-£0.04-315.96
Tristel£42.24M3.98£6.54M£13.6625.72

In the previous week, BATM Advanced Communications had 1 more articles in the media than Tristel. MarketBeat recorded 1 mentions for BATM Advanced Communications and 0 mentions for Tristel. BATM Advanced Communications' average media sentiment score of 1.35 beat Tristel's score of 1.03 indicating that BATM Advanced Communications is being referred to more favorably in the media.

Company Overall Sentiment
BATM Advanced Communications Positive
Tristel Positive

42.4% of BATM Advanced Communications shares are owned by institutional investors. Comparatively, 50.4% of Tristel shares are owned by institutional investors. 26.2% of BATM Advanced Communications shares are owned by company insiders. Comparatively, 4.9% of Tristel shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

BATM Advanced Communications pays an annual dividend of GBX 1 per share and has a dividend yield of 7.3%. Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 3.7%. BATM Advanced Communications pays out -2,321.5% of its earnings in the form of a dividend. Tristel pays out 95.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. BATM Advanced Communications is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Tristel beats BATM Advanced Communications on 9 of the 17 factors compared between the two stocks.

Get BATM Advanced Communications News Delivered to You Automatically

Sign up to receive the latest news and ratings for BVC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BVC vs. The Competition

MetricBATM Advanced CommunicationsMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£72.27M£3.48B£5.37B£2.53B
Dividend Yield3.52%1.99%5.44%4.96%
P/E Ratio-315.9618.5822.09134.07
Price / Sales0.55442.71398.07226,854.53
Price / Cash2.12146.5438.2028.07
Price / Book0.582.726.704.48
Net Income-£278,261.31£99.80M£3.20B£5.82B
7 Day Performance-2.79%2.11%5.27%8.71%
1 Month Performance-4.69%-4.41%-4.75%7.31%
1 Year Performance-27.12%111.17%17.44%25.12%

BATM Advanced Communications Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
N/AGBX 13.61
-3.1%
N/A-26.1%£72.27M£130.32M-315.96980News Coverage
Gap Up
TSTL
Tristel
N/AGBX 348.75
-1.8%
N/A-24.4%£166.60M£42.24M25.52208Gap Down
SPEC
INSPECS Group
N/AGBX 40.48
+1.2%
N/A-24.0%£41.16M£195.14M-10.021,673Gap Up
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
CNSL
Cambridge Nutritional Sciences
N/AGBX 2.55
-5.5%
N/AN/A£6.07M£9.77M-362.103,200Gap Down
High Trading Volume
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
CTEC
ConvaTec Group
1.7742 of 5 stars
GBX 256.20
+0.5%
GBX 301.67
+17.7%
-9.4%£6.52B£2.71B43.1510,000
AMS
Advanced Medical Solutions Group
2.2573 of 5 stars
GBX 186.46
+2.0%
GBX 300
+60.9%
-7.8%£402.62M£132.18M36.1310News Coverage
HZD
Horizon Discovery Group plc (HZD.L)
N/AN/AN/AN/A£302.98M£54.63M-33.55416
AGY
Allergy Therapeutics
N/AGBX 6
-4.8%
N/A+128.1%£294.90M£72.18M-5.78612News Coverage
Gap Up
High Trading Volume
FARN
Faron Pharmaceuticals Oy
N/AGBX 205.20
-2.3%
N/A+65.2%£275.49MN/A-5.4934News Coverage

Related Companies and Tools


This page (LON:BVC) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners